Delhi HC quashes Centre's ban on Oxytocin production, sale
The Delhi High Court has turned down the Centre's decision to ban private companies from producing and selling Oxytocin, a drug used to induce labour and control excessive bleeding during childbirth. It said the decision was without scientific basis and had a "deleterious effect", especially on women. The Centre had claimed its decision would prevent Oxytocin's misuse in dairy farming. 